Neurotechnology & Digital Health
Axonetic develops neurotechnology solutions that bridge human cognition and digital health—enabling people to live, work, and thrive at their highest potential.
Our Mission
At Axonetic, we believe the most powerful interface is the human mind itself. We develop neurotechnology and health platforms grounded in rigorous research, designed to augment cognitive performance, support clinical decision-making, and transform the way organisations understand wellbeing.
Our work is rooted in academic excellence and executive insight—combining cutting-edge neuroscience with proven business strategy to deliver solutions that are not just innovative, but deployable.
Solutions
From enterprise wellness to clinical-grade neurotech, our product suite is designed for organisations that take human performance seriously.
Real-time neurometric dashboards that track executive cognitive load, decision fatigue, and attention states—enabling organisations to optimise performance at scale.
Seamless API-driven integration with clinical health systems, wearables, and EHR platforms, enabling continuous, passive health monitoring for enterprise and clinical environments.
Evidence-based neurofeedback protocols for stress, anxiety, and cognitive rehabilitation, developed in partnership with leading university research groups.
A strategic intelligence layer for CHROs and boards: aggregate wellbeing signals, burnout risk models, and leadership resilience reports—confidential, GDPR-compliant, and actionable.
AI-assisted neurodiagnostic tools for clinicians, synthesising multimodal biosignals into structured clinical insights to support faster, more accurate treatment pathways.
Bespoke neurotechnology strategy consulting for healthcare systems, corporates, and investment groups—drawing on 25+ years of executive experience and active academic research.
Roadmap
Established research partnerships with Universidad Pontificia Comillas and Turicum Innovation. Core IP development and clinical protocol design underway.
Private alpha launch with selected enterprise clients. Cognitive monitoring and wellbeing analytics pilots initiated with partner organisations.
Academic-grade clinical trials in partnership with university medical centres. Publication of neurofeedback efficacy data.
Full commercial launch across European markets. Series A fundraising, regulatory CE marking for medical device modules.
Our Partners
We develop our science in collaboration with world-class institutions, ensuring every product is grounded in peer-reviewed research and clinical rigour.
Interested in a research or commercial partnership? Get in touch →
Early Access
Join our waitlist for early platform access, research updates, and priority onboarding when we launch.
No spam. Unsubscribe at any time. GDPR compliant.